Immunomodulation and vaccine development of atherosclerosis

Chinese Pharmacological Bulletin

Volumn 23, Issue 3, 2007, Pages 285-288

  Xie, Li Xin ^a,b   Fang, Fang ^a   Li, Hui ^b   Fang, Yun Xiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Medical School of Loudi   (China)

Author keywords

Atherosclerosis; Heat shock proteins; Immune responses; Lipoproteins; Vaccine

Indexed keywords

ATHEROSCLEROSIS VACCINE; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; ATHEROSCLEROSIS; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION;

EID: 34249785351     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Skalen K, Gustafsson M, Rydberg E K, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis[J]. Nature,2002, 417(6890):750-4.
2. Lin R, Gan W J, Liu J T. New pathway of atherosclerotic drug therapy-anti-inflammatory effect[J]. Chin Pharmacol Bull,2004, 20(5):499-503.
3. Wang L, Tiang X L, Guo F. Effect of lycopene on the lipid levels of otherosclerosis in rabbits[J]. Chin Pharmacol Bull,2005,21(7): 860-3.
4. Takeuchi O, Akira S. Genetic approaches to the study of Toll-like receptor function[J]. Microbes Infect,2002,4(9):887-95.
5. Michelsen K S, Wong M H, Shah P, et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E [J]. Proc Natl Acad Sci USA,2004,101(29):10679-84.
6. Nilsson J. Regulating protective immunity in atherosclerosis[J]. Circ Res,2005,96(4):395-7.
7. Zhou X, Paulsson G, Stemme S, et al. Hypercholesterolemia is associated with a T helper(Th)1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice[J]. J Clin Invest, 1998,101(8):1717-25.
8. + T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice[J]. Circulation,2000,102(24):2919- 22.
9. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis[J]. Nature,1997,389(6652):737-42.
10. Caligiuri G, Rudling M, Ollivier V, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice[J]. Mol Med,2003,9(1 -2):10-7.
11. Robertson A K, Rudling M, Zhou X, et al. Disruption of TGF-β signaling in T cells accelerates atherosclerosis[J]. J Clin Invest, 2003,112(9):1342-50.
12. Caligiuri G, Nicoletti A, Poirier B, et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice[J]. J Clin Invest,2002,109(6):745-53.
13. Perschinka H, Mayr M, Millonig G, et al. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2003,23(6):1060 -5.
14. Afek A, George J, Gilburd B, et al. Immunization of low-density lipoprotein receptor deficient(LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis[J]. J Autoimmun,2000,14(2):115-21.
15. Palinski W, Ord V A, Plump A S, et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum[J]. Arterioscler Thromb, 1994,14(4):605-16.
16. Tornvall P, Waeg G, Nilsson J, et al. Autoantibodies against modified low-density lipoproteins in coronary artery disease[J]. Atherosclerosis, 2003,167(2):347-53.
17. Fredrikson G N, Hedblad B, Berglund G, et al. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease[J]. Arterioscler Thromb Vasc Biol,2003, 23(5):872-8.
18. Zhou X, Caligiuri G, Hamsten A, et al. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2001,21(1): 108-14.
19. Reardon C A, Miller E R, Blachowicz L, et al. Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice[J]. J Lipid Res,2004,45(7):1347-54.
20. Fredrikson G N, Soderberg I, Lindholm M, et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences[J]. Arterioscler Thromb Vasc Biol,2003,23 (5):879-84.
21. Schiopu A, Bengtsson J, Soderberg I, et al. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis[J]. Circulation,2004,110 (14):2047-52.
22. Friedman P, Hørkkø S, Steinberg D, et al. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration[J]. J Biol Chem,2002,277(9):7010-20.
23. Binder C J, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL[J]. Nat Med, 2003,9(6):736-43.
24. 2- glycoprotein I complexes: new aspects in atherosclerosis[J]. Lupus, 2005,14(9):736-41.
25. Maron R, Sukhova G, Faria A M, et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice[J]. Circulation,2002, 106(13):1708-15.
26. Gurfinkel E P, Fuente R L, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes(FLUVACS) Study[J]. Circulation,2002,105(18): 2143-7.